MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
Merit Medical Systems Total Assets 2011-2026 | MMSI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Merit Medical Systems
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.42 B | 2.33 B | 1.66 B | 1.65 B | 1.66 B | 1.76 B | 1.62 B | 1.11 B | 943 M | 779 M | 747 M | 728 M | 705 M | 447 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.42 B | 447 M | 1.33 B |
Quarterly Total Assets Merit Medical Systems
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.59 B | 2.47 B | 2.42 B | 2.38 B | 2.37 B | 2.33 B | 2.33 B | 1.81 B | 1.84 B | 1.68 B | 1.66 B | 1.63 B | - | 1.63 B | 1.65 B | 1.64 B | 1.64 B | 1.65 B | 1.66 B | 1.66 B | 1.66 B | 1.66 B | 1.76 B | 1.76 B | 1.76 B | 1.76 B | 1.62 B | 1.62 B | 1.62 B | 1.62 B | 1.11 B | 1.11 B | 1.11 B | 1.11 B | 943 M | 943 M | 943 M | 943 M | 779 M | 779 M | 779 M | 779 M | 747 M | 747 M | 747 M | 747 M | 728 M | 728 M | 728 M | 728 M | 705 M | 705 M | 705 M | 705 M | 447 M | 447 M | 447 M | 447 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.59 B | 447 M | 1.33 B |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
25.8 B | $ 19.94 | 1.06 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
ICU Medical
ICUI
|
4.2 B | $ 149.15 | -0.59 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
480 M | $ 2.76 | -1.08 % | $ 205 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.7 M | $ 8.74 | 4.14 % | $ 176 M | USA |
 |
Alcon
ALC
|
30.3 B | $ 80.81 | -0.39 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
609 M | $ 36.51 | -1.19 % | $ 1.71 B | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 66.12 | 0.23 % | $ 3.33 B | USA |
 |
electroCore
ECOR
|
16.1 M | $ 6.56 | -7.61 % | $ 36.2 K | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.33 | 3.51 % | $ 422 M | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 8.25 | 2.61 % | $ 170 M | USA |
 |
STERIS plc
STE
|
10.1 B | $ 261.51 | -0.05 % | $ 25.8 B | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 80.56 | 0.24 % | $ 16 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 135.1 | -0.85 % | $ 7.2 B | USA |
 |
Harvard Bioscience
HBIO
|
137 M | $ 0.51 | -5.5 % | $ 21.6 M | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 118.29 | -0.56 % | $ 5.73 B | USA |
 |
Isoray
ISR
|
341 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
931 M | $ 152.4 | 2.29 % | $ 4.75 B | USA |
 |
LeMaitre Vascular
LMAT
|
552 M | $ 84.52 | 0.79 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
18.7 B | $ 503.25 | -0.85 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
135 M | $ 61.3 | -0.57 % | $ 222 M | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 1.82 | -2.16 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
11.9 M | $ 4.31 | -1.82 % | $ 44.8 M | USA |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.3 | -0.5 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.35 B | $ 23.05 | -1.45 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 39.41 | 0.01 % | $ 130 M | USA |
 |
Predictive Oncology
POAI
|
4.97 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
59.2 M | $ 13.67 | 0.37 % | $ 657 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 202.08 | 0.49 % | $ 58.1 B | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 150.45 | -3.79 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 252.03 | -2.17 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 22.01 | -2.52 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
41.9 M | $ 2.25 | -3.43 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.69 | 0.36 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
510 M | $ 18.85 | -0.48 % | $ 926 M | USA |
 |
Teleflex Incorporated
TFX
|
7.1 B | $ 104.3 | -1.12 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
3.64 B | $ 228.04 | -1.98 % | $ 16.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.75 B | $ 12.36 | 0.73 % | $ 2.51 B | USA |